Skip to content

For laboratory research use only — not for human or veterinary use

ReferenceMelanocortin & pigmentation research

PT-141

Bremelanotide · PT141 · melanocortin agonist

Melanocortin-4-receptor-focused agonist studied in neuroendocrine research.

In development Get notified on release Browse in-stock catalog

About PT-141

PT-141 (bremelanotide) is a cyclic melanocortin peptide, a metabolite-derived analog studied primarily for melanocortin-4-receptor (MC4R) central signaling in neuroendocrine research. TagPep is adding PT-141 as a research-use-only reference material.

Mechanism studied in research

Agonism focused on MC4R in the central nervous system — a pathway studied for neuroendocrine and behavioral signaling in model systems.

Areas of research investigation

  • MC4R central-signaling assays
  • Neuroendocrine research
  • Melanocortin structure-activity studies
  • Behavioral-model research

Laboratory handling

Lyophilized; reconstituted with bacteriostatic or sterile water for research and refrigerated; powder frozen and light-protected.

PT-141 research FAQ

What is PT-141 also called?

PT-141 is also known as bremelanotide, a melanocortin-receptor agonist studied for MC4R central signaling.

Is PT-141 available now?

It is on the research roadmap. Contact TagPep to be notified when a documented batch is released.

Research use only. PT-141 is supplied as a laboratory reference material for in-vitro and research applications. It is not a drug, supplement or medical product, and is not intended for human or veterinary use, consumption, or clinical application.